Medsource Ozone Biomedicals
Finance
08 April, 2026
Xponentia Capital may extend first fund's life, plans more exits
Private equity firm Xponentia Capital Partners may extend the life of its first fund, which is nearing maturity, as some......
General
19 January, 2026
Grapevine: Sun Pharma, Organon, Blackstone, Neysa, Medsource Ozone in news
Sun Pharmaceutical Industries is weighing a potential acquisition of US‑based women’s health and biosimilars player......
